Home › Funds › Chesley Taft & Associates LLC › AZN

Chesley Taft & Associates LLC position in AZN

ASTRAZENECA PLC · Health Care

Chesley Taft & Associates LLC reported holding 91,361 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$14.8M, representing 0.58% of its reported portfolio and ranking #45 among its reported holdings. Chesley Taft & Associates LLC has disclosed AZN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)91.36K sh
Reported value held$14.75M
Portfolio Weight0.58%
First reportedQ3 2024
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Chesley Taft & Associates LLC's AZN position evolved

Chesley Taft & Associates LLC first disclosed a stake in AZN in Q3 2024 at 16,525 shares (US$1.3M). The position peaked in Q1 2026 at 78,802 shares, worth US$15.5M. Across 9 filings, Chesley Taft & Associates LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 91,361 shares valued at US$14.8M — an increase of 10,085 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2024 (shares rose 14% over the following quarter), a 3780% increase in Q1 2025 (shares fell 5% over the following quarter), a 48% trim in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 16.52K $1.29M New
Q4 2024 3.40K $222.77K Reduce
Q1 2025 131.91K $9.70M Add
Q2 2025 132.44K $9.25M Hold
Q3 2025 126.77K $9.73M Reduce
Q4 2025 152.75K $14.04M Add
Q1 2026 78.80K $15.54M Reduce
Q2 2026 81.28K $15.41M Add
Q3 2026 91.36K $14.75M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has Chesley Taft & Associates LLC held AZN?

Chesley Taft & Associates LLC has disclosed AZN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Chesley Taft & Associates LLC's current position in AZN?

As of Q3 2026, Chesley Taft & Associates LLC holds 91.36K shares of AZN (ASTRAZENECA PLC), valued at $14.75M, representing 0.58% of its reported portfolio and ranking #45.

Has Chesley Taft & Associates LLC been buying or selling AZN?

In the latest 13F filing (Q3 2026), Chesley Taft & Associates LLC increased its position in AZN. The position peaked in Q1 2026 at 78.80K shares.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.